Chicago Illinois based Paragon Biosciences Emalex is raising $35,000,010.00 in New Equity Investment.
Chicago, IL – According to filings with the U.S. Securities and Exchange Commission, Paragon Biosciences Emalex is raising $35,000,010.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Jeffrey Aronin played…